Biotech Values

[The Borg]

> As a calibration of my expectations, I give it an 80% chance of greater than $35M in 09Q1.

Better yet, what do you forecast for 4Q08? And I agree with you that slow uptake was to be expected, given the process of getting into hospital formularies. Next quarters numbers should be more telling, but I don't think we'll be able to say one way or another til mid-09.